Published in J Virol Methods on April 14, 2011
Genome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells. BMC Genomics (2012) 0.77
Fluorescence-Based Bioassays for the Detection and Evaluation of Food Materials. Sensors (Basel) (2015) 0.75
Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis (2005) 2.33
Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. J Infect Dis (2006) 1.98
Identification of Listeria species by microarray-based assay. J Clin Microbiol (2002) 1.87
Medical applications of microarray technologies: a regulatory science perspective. Nat Genet (2002) 1.67
Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children. Pediatr Infect Dis J (2012) 1.45
Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses. PLoS One (2015) 1.41
Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res (2005) 1.29
Microarray-based identification of thermophilic Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J Clin Microbiol (2003) 1.21
Biomarkers in the age of omics: time for a systems biology approach. OMICS (2011) 1.13
Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol (2004) 1.08
Detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides. J Virol Methods (2003) 1.06
Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines. Proc Natl Acad Sci U S A (2010) 1.04
Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol (2005) 1.00
Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. J Infect Dis (2013) 0.98
Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis (2007) 0.98
Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology (2002) 0.96
Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine (2005) 0.96
Immunisation against poliomyelitis: moving forward. Lancet (2008) 0.93
Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s. Virology (2007) 0.93
Quantitative one-step RT-PCR assay for rapid and sensitive identification and titration of polioviruses in clinical specimens. J Virol Methods (2013) 0.92
Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor. Proc Natl Acad Sci U S A (2013) 0.91
Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis. J Virol (2011) 0.91
Future of polio vaccines. Expert Rev Vaccines (2009) 0.91
Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method. Biologicals (2005) 0.89
Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol (2003) 0.87
Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus. J Med Virol (2011) 0.85
Microarray assay for detection and discrimination of Orthopoxvirus species. J Med Virol (2006) 0.85
Algorithmic assessment of vaccine-induced selective pressure and its implications on future vaccine candidates. Adv Bioinformatics (2010) 0.84
Repertoire of antibodies against type 1 poliovirus in human sera. J Virol Methods (2010) 0.84
Microarray-based assay for the detection of genetic variations of structural genes of West Nile virus. J Virol Methods (2008) 0.80
Don't drop current vaccine until we have new ones. Nature (2005) 0.80
Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis (2010) 0.79
Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene. J Med Virol (2007) 0.78
Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV). Biologicals (2005) 0.78
Environmental surveillance of viruses by tangential flow filtration and metagenomic reconstruction. Euro Surveill (2016) 0.76
Monovalent oral poliovirus vaccines--a good tool but not a total solution. N Engl J Med (2008) 0.75
Determination of poliovirus-specific IgA in saliva by ELISA tests. J Virol Methods (2005) 0.75